-
March 10, 2022 My Favorite Psychedelic Stocks: Part 1Our resident Psychedelic Investor details five companies he thinks are in strong position to win...
-
February 18, 2022 Psychedelic Business Spotlight – February 18This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to...
-
February 17, 2022 Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based Therapies"The need for new and more effective treatments across the mental health spectrum is more...
-
February 11, 2022 Psychedelic Business Spotlight – February 11This week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads...
-
February 4, 2022 4 Tips for Investing in Psychedelic Stocks During a Market DownturnFriendly advice for responsibly managing speculative bets on psychedelic stocks that may rise like a...
-
January 18, 2022 Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary TechnologyThe technology may be more broadly used in the future for neuroscientific or physiological studies...
-
December 30, 2021 2021: A Year in Review for the Psychedelics BusinessOur resident Psychedelic Investor looks back at some of this growing industry's biggest moments and...
-
December 17, 2021 Psychedelic Business Spotlight – December 17This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints...
-
December 3, 2021 Psychedelic Business Spotlight: December 3This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a...
-
November 26, 2021 Psychedelic Business Spotlight: November 26This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big...
